ATE532193T1 - IMPROVED GROUND AREA DESIGN OF AN INTERNALLY GROUNDED THROUGH FILTER CAPACITOR FOR HUMAN IMPLANT AND OTHER APPLICATIONS - Google Patents

IMPROVED GROUND AREA DESIGN OF AN INTERNALLY GROUNDED THROUGH FILTER CAPACITOR FOR HUMAN IMPLANT AND OTHER APPLICATIONS

Info

Publication number
ATE532193T1
ATE532193T1 AT01118707T AT01118707T ATE532193T1 AT E532193 T1 ATE532193 T1 AT E532193T1 AT 01118707 T AT01118707 T AT 01118707T AT 01118707 T AT01118707 T AT 01118707T AT E532193 T1 ATE532193 T1 AT E532193T1
Authority
AT
Austria
Prior art keywords
applications
filter capacitor
ground area
improved ground
area design
Prior art date
Application number
AT01118707T
Other languages
German (de)
Inventor
Richard L Brendel
Robert A Stevenson
Original Assignee
Greatbatch Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/657,123 external-priority patent/US6529103B1/en
Application filed by Greatbatch Ltd filed Critical Greatbatch Ltd
Application granted granted Critical
Publication of ATE532193T1 publication Critical patent/ATE532193T1/en

Links

AT01118707T 2000-09-07 2001-08-03 IMPROVED GROUND AREA DESIGN OF AN INTERNALLY GROUNDED THROUGH FILTER CAPACITOR FOR HUMAN IMPLANT AND OTHER APPLICATIONS ATE532193T1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/657,123 US6529103B1 (en) 2000-09-07 2000-09-07 Internally grounded feedthrough filter capacitor with improved ground plane design for human implant and other applications

Publications (1)

Publication Number Publication Date
ATE532193T1 true ATE532193T1 (en) 2011-11-15

Family

ID=44898353

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01118707T ATE532193T1 (en) 2000-09-07 2001-08-03 IMPROVED GROUND AREA DESIGN OF AN INTERNALLY GROUNDED THROUGH FILTER CAPACITOR FOR HUMAN IMPLANT AND OTHER APPLICATIONS

Country Status (1)

Country Link
AT (1) ATE532193T1 (en)

Similar Documents

Publication Publication Date Title
DE60112527D1 (en) Crosslinker systems of monohydroxyalkylurea and polysaccharide
DE10084643T1 (en) Prevention and treatment of an amyloidogenic disease
DE60311022D1 (en) Surgical instrument and tape for the treatment of stress incontinence in women
DE69528043T2 (en) UNIT OF CATHETER AND CHECK VALVE
DE60010662D1 (en) COMBINATIONS OF FORMOTEROL AND FLUTICASONPROPIONATE FOR ASTHMA
DE60108847D1 (en) TUBULAR FLAP AND STENT FOR THE TREATMENT OF VASCULAR FLUID
ATE389618T1 (en) PRE-COAST FILTER MEDIA AND METHODS OF MANUFACTURING AND USE
DE60026037D1 (en) DIELECTRIC RESONATOR AND DIELECTRIC FILTER
ATE493149T1 (en) PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE
DE60226111D1 (en) DIELECTRIC FILTER AND ANTENNA VARIETIES
DE50211255D1 (en) COMBINATIONS OF HERBICIDES AND SAFENERN
FR2807425B1 (en) NON-REDUCING DIELECTRIC CERAMIC AND MONOLITIC CERAMIC CAPACITOR USING THE SAME
DE60122571D1 (en) MEDICAL DEVICE AND METHOD FOR THE APPLICATION OF THIS DEVICE
DE60017706D1 (en) Filter cartridge and condenser
EP1639908A4 (en) Folding structure of disposable underpants and disposable underpants
DE60134009D1 (en) USE OF IL-18 INHIBITORS FOR THE TREATMENT AND / OR PREVENTION OF ATHEROSCLEROSIS
PL369521A1 (en) Heterocyclic derivatives of glycinamide and their medical use
DE60035730D1 (en) Combination of connector and mounting unit
DE602004021758D1 (en) Resonator and dielectric filter
DE60138733D1 (en) MEDICAMENT FOR TREATMENT AND PREVENTION OF NEUROGENIC PAIN
AU2003273843A8 (en) Use of skin-protecting substances
DE60328931D1 (en) Aqueous preparations of perfluoropolyether phosphates and their use for the oil-repellent treatment of paper
DE60001725D1 (en) USE OF THE SAREDUTANT AND ITS PHARMACEUTICAL ACCEPTABLE SALTS FOR THE TREATMENT OF HEAVY DEPRESSION
ATE532193T1 (en) IMPROVED GROUND AREA DESIGN OF AN INTERNALLY GROUNDED THROUGH FILTER CAPACITOR FOR HUMAN IMPLANT AND OTHER APPLICATIONS
DE602004016830D1 (en) PHARMACEUTICAL COMPOSITIONS COMPRISING A COMBINATION OF RAPAMYCIN OR ITS DERIVATIVES AND PIMECROLIMUS FOR THE TREATMENT OF INFLAMMATORY ENTIRE DISEASE (IBD)